BioSig Technologies, Inc. Share Price
Equities
BSGM
US09073N3008
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +5.38% | -2.84% | -71.16% |
04-16 | BioSig Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-12 | BioSig Technologies Inc. Issues Promissory Note to an Investor for $500,000 | CI |
Sales 2024 * | 100K 8.01M | Sales 2025 * | 1M 80.05M | Capitalization | 15.34M 1.23B |
---|---|---|---|---|---|
Net income 2024 * | -6M -480M | Net income 2025 * | -12M -961M | EV / Sales 2024 * | 153 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 15.3 x |
P/E ratio 2024 * |
-1.83
x | P/E ratio 2025 * |
-1.05
x | Employees | 4 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.19% |
1 day | +5.38% | ||
1 week | -2.84% | ||
Current month | +107.26% | ||
1 month | +191.49% | ||
3 months | -37.16% | ||
6 months | -72.87% | ||
Current year | -71.16% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | 02-26 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 23/02/09 |
Chief Tech/Sci/R&D Officer | 74 | 23/02/09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 23/02/09 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | 02-26 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 1.37 | +5.38% | 96,068 |
25/04/24 | 1.3 | -1.52% | 55,164 |
24/04/24 | 1.32 | -10.81% | 154,915 |
23/04/24 | 1.48 | -4.82% | 83,619 |
22/04/24 | 1.555 | +10.28% | 216,573 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-71.16% | 15.34M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- BSGM Stock